Home > Products > Biosimilars

BioSIM anti-Human CTLA-4/CD152 Antibody (Tremelimumab Biosimilar), Research Grade

Catalog: SIM0168
Cost advantage to: SIM0046
Isotype: IgG2-kappa
Product Details Specifications Application References Related Products

Product Details

This biosimilar, sharing therapeutic Tremelimumab’s variable regions, is a fully human monoclonal antibody binding human CTLA-4 (CD152)—a 33 kDa CD28-family receptor on activated T/B cells that negatively regulates immunity. It blocks CTLA-4’s inhibitory signal (aiding T cells to kill cancer cells, for checkpoint blockade) and is a non-complement-fixing IgG2, unlike CTLA-4-targeting Ipilimumab (IgG1).
 

Specifications

Product Name BioSIM anti-Human CTLA-4/CD152 Antibody (Tremelimumab Biosimilar), Research Grade
Size 1mg/5mg
Isotype IgG2-kappa
Target CTLA-4/CD152
Other Names Ticilimumab, CP-675, CP-675, 206, CP-675206clone11.2.1, CAS: 745013-59-6
CAS 745013-59-6
Reactivity Human
Host Species Human
Background This biosimilar, sharing therapeutic Tremelimumab’s variable regions, is a fully human monoclonal antibody binding human CTLA-4 (CD152)—a 33 kDa CD28-family receptor on activated T/B cells that negatively regulates immunity. It blocks CTLA-4’s inhibitory signal (aiding T cells to kill cancer cells, for checkpoint blockade) and is a non-complement-fixing IgG2, unlike CTLA-4-targeting Ipilimumab (IgG1).
Applications ELISA, FACS, Functional assay, Research in vivo
Purification Protein A/G
Storage To ensure appropriate storage, Please avoid repeated freeze thaw cycles. Keep the product at 4°C for short-term needs (1–2 weeks); Store at -20°C for up to 12 months.  For long-term storage, store at -80°C.
Shipping 2-8°C with blue ice
Concentration Lot specific, generally ≥ 5.0 mg/ml
Shelf Life 12 months from the date of receipt if stored as recommended
Formulation PBS, pH 7.4, contains no stabilizers or preservatives
Sterility 0.2 μM filtered
Endotoxin ≤ 1.0 EU/mg
Purity 99%

Application References

Related Products